Download PDF
Zeitschrift für Orthomolekulare Medizin 2015; 2(02): 15-18
DOI: 10.1055/s-0035-1547555
Wissen
Hippokrates Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG Stuttgart · New York

Alzheimer: Prävention mit dem Kochtopf!

Uwe Gröber
Further Information

Publication History

Publication Date:
09 July 2015 (online)

    Permissions and Reprints

Zusammenfassung

Die Demenz vom Typ Alzheimer (DAT) ist weit verbreitet und die Prävalenz wird weiter zunehmen. Bei dieser neurodegenerativen Erkrankung handelt sich um einen multifaktoriellen Prozess, dessen Ursache nicht eindeutig geklärt ist. Einen wichtigen Risikofaktor für DAT stellen AGEs dar. Eine AGE-arme Ernährung bzw. die mediterrane Kost wirken vermutlich präventiv.

Schlüsselwörter

Alzheimer - Demenz - DAT - Neurodegeneration - β-Amyloid-Aggregate - Diabetes Typ 3 - Advanced Glycation Endproducts (AGEs) - mediterrane Ernährung
 

  • Literatur

  • 1 World Alzheimer Report − Dementia and Risk Reduction. Aan analysis of protective and modifiable factors. 2014
    Google Scholar
  • 2 Hallauer JFS, Smala A, Berger K. Untersuchung von Krankheitskosten bei Patienten mit Alzheimer-Erkrankung in Deutschland. Gesundheitsökon Qualitätsmanag 2001; 5: 73-79
    Google Scholar
  • 3 Querfurth HW, LaFerla FM. Alzheimer’s ­disease. N Engl J Med 2010; 362 (4): 329-344
    CrossrefGoogle Scholar
  • 4 Gröber U. Alzheimer: Neuroenhancement mit α-Liponsäure. ZKM 2012; 1: 45-49
    Google Scholar
  • 5 Perrone L, Sbai O, Nawroth PP, Bierhaus A. The complexity of sporadic alzheimer’s disease pathogenesis: the role of rAGE as therapeutic target to promote neuroprotection by inhibiting neurovascular dysfunction. Int J Alzheimers Dis 2012; 2012: 734956-
    Google Scholar
  • 6 Wang KC, Woung LC, Tsai MT et al. Risk of Alzheimer’s disease in relation to diabetes: a population-based cohort study. Neuroepidemiology 2012; 38 (4): 237-244
    CrossrefGoogle Scholar
  • 7 Steen E, Terry BM, Rivera EJ, et al. Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer’s disease − is this type 3 diabetes?. J Alzheimers Dis 2005; 7(1): 63-80
    Google Scholar
  • 8 Norton S, Matthews FE, Barnes DE, et al. Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol 2014; 13 (8): 788-794
    CrossrefPubMedGoogle Scholar
  • 9 Rett K. Bessere Chancen für Nerven und Gefäße. Stuttgart: Georg Thieme Verlag; 2011
    Google Scholar
  • 10 Schiekofer S, Andrassy M, Chen J et al. Acute hyperglycemia causes intracellular formation of CML and activation of ras, p42/44 MAPK, and nuclear factor kappaB in PBMCs. Diabetes 2003; 52 (3): 621-633
    CrossrefGoogle Scholar
  • 11 Negrean M, Stirban A, Stratmann B et al. Effects of low- and high-advanced glycation endproduct meals on macro- and microvascular endothelial function and oxidative stress in patients with type 2 diabetes mellitus. Am J Clin Nutr 2007; 85 (5): 1236-1243
    Google Scholar
  • 12 Uribarri J, Stirban A, Sander D et al. Single oral challenge by advanced glycation end products acutely impairs endothelial function in diabetic and nondiabetic subjects. Diabetes Care, 2007; 30 (10): 2579-2582
    CrossrefGoogle Scholar
  • 13 Stirban A. Die Bedeutung von AGEs und ROS bei Atherosklerose. Herz 2010; 3: 170-180
    Google Scholar
  • 14 Semba RD, Nicklett EJ, Ferrucci L. Does accumulation of advanced glycation end products contribute to the aging pheno­type?. J Gerontol A Biol Sci Med Sci 2010; 65 (9): 963-975
    Google Scholar
  • 15 Cai W, Uribarri J, Zhu L et al. Oral glyco­toxins are a modifiable cause of dementia and the metabolic syndrome in mice and humans. Proc Natl Acad Sci USA 2014; 111 (13): 4940-4945
    CrossrefGoogle Scholar
  • 16 Perrone L, Grant WB. Observational and ecological studies of dietary advanced glycation end products in national diets and Alzheimer’s disease incidence and prevalence. J Alzheimers Dis 2015; 45 (3): 965-979
    Google Scholar
  • 17 Li XH, Du LL, Cheng XS et al. Glycation exacerbates the neuronal toxicity of β-amyloid. Cell Death Dis 2013; 4: e673-
    CrossrefGoogle Scholar
  • 18 Singh B, Parsaik AK, Mielke MM et al. Association of mediterranean diet with mild cognitive impairment and Alzheimer’s ­disease: a systematic review and meta-analysis. J Alzheimers Dis 2014; 39 (2): 271-282
    Google Scholar
  • 19 Estruch R, Ros E, Salas-Salvadó J et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368 (14): 1279-1290
    CrossrefPubMedGoogle Scholar